| Literature DB >> 30724266 |
Lian-Qun Wu1,2, Pei Mou2, Zi-Yu Chen2, Jin-Wei Cheng2, Qi-Hua Le1, Ji-Ping Cai2, Rui-Li Wei2.
Abstract
BACKGROUND Thyroid-associated ophthalmopathy (TAO) is a common endocrine autoimmune disease. The present study explored corneal nerve changes in TAO patients. MATERIAL AND METHODS Thirty-eight Chinese TAO patients and 20 healthy individuals were included in the study. Central corneal subbasal nerve density and morphology were evaluated with in vivo laser scanning confocal microscopy and quantified using automated CCmetrics software. RESULTS The values of the central corneal subbasal nerve plexus parameters of both active and inactive TAO patients were significantly decreased compared with those of controls, including corneal nerve fiber density (CNFD) (P<0.001 for both), corneal nerve branch density (CNBD) (P<0.001 for both), corneal nerve fiber length (CNFL) (P<0.001 for both), corneal nerve fiber total branch density (CTBD) (P<0.001 for both), corneal nerve fiber area (CNFA) (P<0.001 for both), corneal nerve fiber width (CNFW) (P=0.046, P=0.027, respectively), and corneal nerve fiber fractal dimension (ACNFrD) (P<0.001 for both). In addition, CNFD and ACNFrD values were significantly lower in the active TAO patients compared with those in the inactive TAO patients (P=0.020, P=0.002, respectively). There were significant correlations between CNFD, CNBD, CNFL, CTBD, CNFA, and ACNFrD and the ocular surface parameters and activity assessment items. CONCLUSIONS Abnormal corneal subbasal nerves were observed in both active and inactive Chinese TAO patients, suggesting that nerve degeneration is associated with the disease. However, the exact underlying mechanisms remain to be elucidated.Entities:
Mesh:
Year: 2019 PMID: 30724266 PMCID: PMC6373222 DOI: 10.12659/MSM.912310
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Demographic results and clinical profiles of TAO patients and healthy subjects.
| Active TAO (N=14) | Inactive TAO (N=24) | Control (N=20) | ||
|---|---|---|---|---|
| Gender (Male/Female) | 5/9 | 5/19 | 7/13 | 0.491 |
| Age (years) | 43.50±5.71 | 40.00±7.64 | 44.10±7.28 | 0.132 |
| Time since symptom onset (month) | 15.64±13.01 | 57.79±42.82 | N/A | <0.001 |
| Clinical activity score | 5.71±1.27 | 1.17±0.76 | 0 | <0.001 |
| Severity of TAO (mild/moderate-to-severe/very severe) | 0/14/0 | 5/19/0 | N/A | 0.137 |
| FT3 (pmol/L) | 5.28±1.89 | 4.59±0.65 | 4.51±0.49 | 0.086 |
| FT4 (pmol/L) | 17.09±5.02 | 15.25±3.74 | 15.31±1.18 | 0.248 |
| TSH (mU/L) | 3.64±6.34 | 2.44±2.47 | 2.41±0.94 | 0.538 |
| Smoking habits (smoker/ex-smoker/nonsmoker) | 3/2/9 | 6/2/16 | 7/1/12 | 0.817 |
N/A – not applicable for this group; FT3 – free triiodothyronine; FT4 – free thyroxine; TSH – thyroid stimulating hormone.
Fisher’s exact test;
ANOVA;
t test.
Ocular surface parameters and activity assessment of TAO patients and control subjects.
| Active TAO (N=14) | Inactive TAO (N=24) | Control (N=20) | ||
|---|---|---|---|---|
| Proptosis (mm) | 21.07±2.46 | 19.69±2.13 | 15.03±0.73 | <0.001 |
| Lagophthalmos (mm) | 1.25 (0, 3.5) | 0 (0, 1.75) | 0 (0, 0) | <0.001 |
| Palpebral fissure height (mm) | 11.00±2.60 | 10.92±1.86 | 7.65±0.99 | <0.001 |
| Redness of eyelids (%) | 100% (14/14) | 4.2% (1/24) | 0% (0/20) | <0.001 |
| Swelling of eyelids (%) | 100% (14/14) | 75.0% (18/24) | 0% (0/20) | 0.067 |
| Redness of conjunctiva (%) | 100% (14/14) | 33.3% (8/24) | 0% (0/20) | <0.001 |
| Swelling of conjunctiva (%) | 100% (14/14) | 0% (0/24) | 0% (0/20) | <0.001 |
| Swelling of caruncle (%) | 78.6% (11/14) | 0% (0/24) | 0% (0/20) | <0.001 |
| OSDI (score) | 52.09 (46.36, 56.25) | 25.00 (20.83, 39.06) | 0 (0, 1.56) | <0.001 |
| BUT (seconds) | 5.17±2.22 | 6.45±2.95 | 11.62±1.67 | <0.001 |
| Fluorescein staining (score) | 3.71±4.14 | 1.83±2.08 | 0 | <0.001 |
| Schirmer test (mm) | 5.32±2.11 | 6.27±2.93 | 12.65±1.95 | <0.001 |
| Corneal sensitivity | 5.33±0.66 | 5.46±0.47 | 5.80±0.32 | 0.014 |
ANOVA;
active TAO vs. inactive TAO, Mann-Whitney U nonparametric test;
active TAO vs. inactive TAO, Fisher’s exact test.
Confocal microscopy data of TAO patients and control subjects.
| Active TAO (N=14) | Inactive TAO (N=24) | Control (N=20) | ||
|---|---|---|---|---|
| Corneal nerve fiber density (n/mm2) | 12.3±4.7 | 17.2±6.2 | 28.4±6.7 | <0.001 |
| Corneal nerve branch density (n/mm2) | 13.2±8.6 | 20.8±13.1 | 41.9±16.0 | <0.001 |
| Corneal nerve fiber length (mm/mm2) | 10.4±3.0 | 12.3±3.1 | 17.6±3.6 | <0.001 |
| Corneal nerve fiber total branch density (n/mm2) | 27.6±11.8 | 36.9±17.0 | 56.5±19.8 | <0.001 |
| Corneal nerve fiber area (mm2/mm2) | 0.005±0.001 | 0.005±0.002 | 0.007±0.002 | <0.001 |
| Corneal nerve fiber width (mm/mm2) | 0.02±0.001 | 0.02±0.001 | 0.02±0.001 | 0.050 |
| Corneal nerve fiber fractal dimension | 1.4±0.04 | 1.5±0.04 | 1.5±0.03 | <0.001 |
ANOVA.
Figure 1Representative confocal microscopic images of the corneal subbasal nerve plexus in TAO patients and control subjects. (A) Corneal subbasal nerve plexus of a normal subject and (B) the same confocal microscopic image analyzed by the automated CCmetrics software. The quantitative analysis results were corneal nerve fiber density (CNFD)=31.2 n/mm2, corneal nerve branch density (CNBD)=43.7 n/mm2, corneal nerve fiber length (CNFL)=17.0 mm/mm2, corneal nerve fiber total branch density (CTBD)=50.0 n/mm2, corneal nerve fiber area (CNFA)=0.006 mm2/mm2, corneal nerve fiber width (CNFW)=0.02 mm/mm2, and corneal nerve fiber fractal dimension (ACNFrD)=1.5. (C) Corneal subbasal nerve plexus of an active TAO patient, and the quantitative analysis results were CNFD=18.7 n/mm2, CNBD=43.7 n/mm2, CNFL=13.3 mm/mm2, CTBD=62.5 n/mm2, CNFA=0.007 mm2/mm2, CNFW=0.02 mm/mm2, and ACNFrD=1.5. (D) Corneal subbasal nerve plexus of an inactive TAO patient, and the quantitative analysis results were CNFD=18.7 n/mm2, CNBD=12.5 n/mm2, CNFL=7.6 mm/mm2, CTBD=18.7 n/mm2, CNFA=0.002 mm2/mm2, CNFW=0.03 mm/mm2, and ACNFrD=1.4. Note the decreased number of nerves and increased tortuosity in active TAO (C) and inactive TAO patients (D).
Correlations between the confocal microscopy data and clinical data.
| CNFD | CNBD | CNFL | CTBD | CNFA | CNFW | ACNFrD | ||
|---|---|---|---|---|---|---|---|---|
| Severity of TAO | r | −0.046 | 0.050 | −0.053 | −0.142 | −0.106 | −0.202 | −0.018 |
| P | 0.783 | 0.767 | 0.751 | 0.395 | 0.525 | 0.223 | 0.916 | |
| Redness of eyelids | r | −0.563 | −0.498 | −0.469 | −0.449 | −0.347 | 0.171 | −0.556 |
| P | 0.201 | |||||||
| Swelling of eyelids | r | −0.639 | −0.582 | −0.598 | −0.548 | −0.505 | 0.220 | −0.623 |
| P | 0.098 | |||||||
| Redness of conjunctiva | r | −0.462 | −0.412 | −0.416 | −0.357 | −0.350 | 0.058 | −0.475 |
| P | 0.663 | |||||||
| Swelling of conjunctiva | r | −0.513 | −0.472 | −0.436 | −0.409 | −0.354 | 0.108 | −0.525 |
| P | 0.418 | |||||||
| Swelling of caruncle | r | −0.500 | −0.514 | −0.338 | −0.406 | −0.225 | 0.041 | −0.456 |
| P | 0.761 | |||||||
| OSDI | r | −0.601 | −0.526 | −0.571 | −0.440 | −0.402 | 0.196 | −0.586 |
| P | 0.141 | |||||||
| BUT | r | 0.434 | 0.367 | 0.382 | 0.245 | 0.194 | −0.022 | 0.440 |
| P | 0.870 | |||||||
| Fluorescein staining score | r | −0.292 | −0.259 | −0.249 | −0.190 | −0.144 | 0.181 | −0.216 |
| P | 0.050 | 0.060 | 0.154 | 0.279 | 0.174 | 0.103 | ||
| Schirmer test score | r | 0.598 | 0.547 | 0.545 | 0.478 | 0.407 | −0.245 | 0.595 |
| P | 0.064 | |||||||
| Corneal sensitivity | r | 0.272 | 0.315 | 0.258 | 0.254 | 0.188 | −0.202 | 0.217 |
| P | 0.051 | 0.055 | 0.157 | 0.129 | 0.102 |
Bold values indicate statistical significance (P<0.05).